封面
市場調查報告書
商品編碼
1423644

2030 年強度調控放射治療(IMRT) 市場預測:按放射類型、應用、最終用戶和地區進行的全球分析

Intensity Modulated Radiation Therapy Market Forecasts to 2030 - Global Analysis By Radiation Type (Proton Radiation, Electron Radiation, Photon Radiation and Other Radiation Types), Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,2023 年全球強度調控放射治療(IMRT) 市場規模為 22 億美元,預計預測期內複合年成長率為 6.8%,到 2030 年將達到 35 億美元。

強度調控放射治療(IMRT) (IMRT) 是一種精確放射治療技術,可在多個角度調整放射束強度。這允許對癌組織進行高劑量照射,同時最大限度地減少對周圍健康結構的暴露。與傳統放射線治療相比,IMRT 的精確度提高了治療效果並減少了副作用。

根據美國癌症協會估計,2022年美國將新增190萬癌症病例。

全球癌症盛行率不斷上升

世界各地的癌症發病率持續飆升,增加了對先進和精確治療方法的需求。 IMRT 能夠提供目標劑量,同時最大限度地減少對周圍健康組織的損害,已成為腫瘤學領域的關鍵技術。各種癌症的盛行率不斷增加以及人口老化增加了對有效和客製化治療方法的需求。這一趨勢支持 IMRT 作為綜合癌症治療的關鍵參與者,將其定位為不斷發展的癌症治療領域的關鍵解決方案。

治療費用高

IMRT 的先進技術涉及精確的放射治療、專業設備和熟練的人員,因此治療費用昂貴。這種財務負擔可能會拖累醫療機構和患者,特別是在醫療預算有限或報銷政策不佳的地區。由於成本考量可能會削弱人們對更具成本效益的治療方法的興趣,從而影響 IMRT 的市場佔有率,因此這種威脅會加劇。

個人化醫療整合

根據個別患者特徵(例如基因組成和腫瘤概況)客製化治療,可以提高 IMRT 的準確性和有效性。個人化方法可以最佳化治療計劃、最大限度地減少副作用並改善治療結果。這種協同效應與醫療保健領域精準醫療的更廣泛趨勢一致,促進更多以患者為中心和有針對性的治療方法。 IMRT 與個人化醫療無縫整合的能力不僅擴大了 IMRT 的範圍,而且使其處於尖端腫瘤治療的前沿,推動需求和市場成長。

部署複雜度

IMRT 技術複雜,需要醫療保健專業人員(包括放射腫瘤學家和醫學物理學家)進行專門培訓,這可能導致技術人員短缺。 IMRT 涉及的複雜規劃和交付流程不僅需要先進的設備,還需要對治療規劃軟體有細緻的了解。將 IMRT 整合到現有的醫療保健系統中需要大量的基礎設施投資和繼續教育舉措。此外,掌握 IMRT 技術的學習曲線可能會阻礙快速和廣泛的普及,特別是在資源有限或醫療保健差距較大的地區。

COVID-19 的影響:

COVID-19大流行對市場產生了重大影響。這場危機導致醫療保健服務中斷並推遲了選擇性手術,包括非緊急癌症治療。與 COVID-19 相關的醫療保健資源的重新分配和優先排序使常規癌症治療的醫療保健設施的可用性緊張,並影響了 IMRT 的採用。此外,疫情後的經濟挑戰和醫療保健預算限制可能會影響投資決策並減緩市場成長。儘管遇到這些挫折,隨著醫療保健系統適應不斷變化的大流行後形勢,IMRT 在晚期癌症治療中的重要性仍然是康復的驅動力。

乳癌領域預計在預測期內規模最大

乳癌領域預計將出現良好的成長。 IMRT 輻射束調節的精確性能夠對乳房腫瘤進行針對性照射,同時最大限度地減少對周圍健康組織的暴露。因此,與傳統放射線治療相比,治療效果提高,副作用減少。全球乳癌發病率不斷上升,以及人們對先進和精準治療方法的日益偏好,推動了乳癌病例對 IMRT 的需求,這些治療有助於改善接受乳癌放射線治療的患者的治療結果和生活品質。的背景。

預計醫院業在預測期內複合年成長率最高。

預計醫院業在預測期內複合年成長率最高。這些醫療機構投資了最先進的 IMRT 技術和基礎設施,使患者能夠接受先進的放射線治療。醫院與放射腫瘤科醫師和技術人員合作,提供精準、個人化的 IMRT 治療。 IMRT 在醫院內的整合將增強癌症治療能力,實現有針對性的治療,並最大限度地減少副作用。醫院作為主要相關人員,為 IMRT 在更廣泛的醫療保健環境中的發展和可近性做出了重大貢獻。

比例最高的地區:

由於先進的醫療基礎設施、高癌症發病率以及積極的研發活動,預計北美市場在預測期內將繼續佔據大部分市場佔有率。該地區擁有完善的報銷政策並注重創新,這有助於普及。此外,醫療保健專業人員和患者對 IMRT 益處的認知不斷提高,也提高了市場佔有率。主要市場參與企業和研究機構之間的合作進一步加強了北美的地位,並確保對 IMRT 解決方案的需求持續激增,以滿足該地區不斷變化的癌症治療需求。

複合年成長率最高的地區:

亞太地區在香料朗姆酒市場中發揮關鍵作用,由於癌症發病率上升、醫療基礎設施的進步以及對先進治療方案的認知不斷增強,亞太地區在預測期內的複合年成長率最高。預計這種情況將會發生。由於癌症治療投資的增加,中國、印度和日本等國家處於這一擴張的前沿。該地區龐大的患者群,加上政府改善癌症治療的努力,為 IMRT 的採用創造了肥沃的土壤。

免費客製化服務:

訂閱此報告的客戶可以存取以下免費自訂選項之一:

  • 公司簡介
    • 其他市場參與者的綜合分析(最多 3 家公司)
    • 主要企業SWOT分析(最多3家企業)
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率(註:基於可行性檢查)
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病(COVID-19)的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球強度調控放射治療(IMRT) 市場:依放射型

  • 質子束
  • 電子輻射
  • 光子輻射
  • 碳離子輻射
  • 其他類型的輻射

第6章全球強度調控放射治療(IMRT) 市場:依應用分類

  • 攝護腺癌
  • 肺癌
  • 乳癌
  • 腦腫瘤
  • 婦科癌症
  • 其他用途

第7章全球強度調控放射治療(IMRT) 市場:依最終使用者分類

  • 醫院
  • 獨立放射治療中心
  • 其他最終用戶

第8章全球強度調控放射治療(IMRT) 市場:依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Accuray Incorporated
  • Brainlab AG
  • Varian Medical Systems, Inc
  • Elekta AB
  • Hitachi, Ltd.
  • IBA Worldwide
  • Koninklijke Philips NV
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Raysearch Laboratories
  • Siemens Healthineers AG
Product Code: SMRC24878

According to Stratistics MRC, the Global Intensity Modulated Radiation Therapy Market is accounted for $2.2 billion in 2023 and is expected to reach $3.5 billion by 2030 growing at a CAGR of 6.8% during the forecast period. Intensity Modulated Radiation Therapy (IMRT) is a precise radiotherapy technique that adjusts radiation beam intensity across multiple angles. This allows targeted delivery of higher doses to cancerous tissue while minimizing exposure to surrounding healthy structures. IMRT's precision enhances treatment effectiveness and reduces side effects compared to conventional radiation therapy.

According to the American Cancer Society, in 2022, an estimated 1.9 million new cases of cancer were diagnosed in the U.S.

Market Dynamics:

Driver:

The rising prevalence of cancer worldwide

Cancer rates continue to surge worldwide, there is a heightened demand for advanced and precise treatment modalities. IMRT, with its ability to deliver targeted radiation doses while minimizing damage to surrounding healthy tissues, have emerged as a crucial technology in the oncology landscape. The rising prevalence of diverse cancer types, coupled with an aging population, underscores the need for effective and tailored therapies. This trend propels the adoption of IMRT as a key player in the comprehensive oncological care, positioning it as a vital solution in the evolving landscape of cancer treatment.

Restraint:

High treatment costs

IMRT's sophisticated technology, involving precise radiation delivery, specialized equipment, and skilled personnel, contributes to elevated treatment expenses. This financial burden may deter healthcare institutions and patients, particularly in regions with limited healthcare budgets or where reimbursement policies are insufficient. The threat intensifies as cost considerations may divert attention toward alternative, more cost-effective treatment options, impacting IMRT's market share.

Opportunity:

Personalized medicine integration

Tailoring treatments to individual patient characteristics, such as genetic makeup and tumor profiles, enhances the precision and effectiveness of IMRT. Personalized approaches allow for optimized treatment plans, minimizing side effects and improving outcomes. This synergy aligns with the broader trend in healthcare towards precision medicine, fostering a more patient-centric and targeted therapeutic approach. The ability of IMRT to seamlessly integrate with personalized medicine not only expands its applicability but also positions it at the forefront of cutting-edge oncological care, driving demand and market growth.

Threat:

Complexity of implementation

IMRT's intricate technology demands specialized training for healthcare professionals, including radiation oncologists and medical physicists, leading to a potential shortage of adequately skilled personnel. The sophisticated planning and delivery processes involved in IMRT require not only advanced equipment but also a nuanced understanding of treatment planning software. Integration of IMRT into existing healthcare systems necessitates substantial investments in infrastructure and continuous educational initiatives. Moreover, the learning curve for mastering IMRT techniques may hinder its swift and widespread adoption, particularly in regions with limited resources or healthcare disparities.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the market. The crisis led to disruptions in healthcare services, delaying elective procedures, including non-urgent cancer treatments. Resource reallocation and prioritization of COVID-19-related care strained the availability of medical facilities for routine cancer therapies, affecting the adoption of IMRT. Moreover, economic challenges and healthcare budget constraints in the wake of the pandemic may have influenced investment decisions, potentially slowing down the market's growth. Despite these setbacks, the importance of IMRT in advanced cancer care continues to drive its recovery as healthcare systems adapt to the evolving post-pandemic landscape.

The breast cancer segment is expected to be the largest during the forecast period

The breast cancer segment is expected to have a lucrative growth. IMRT's precision in adjusting radiation beams allows for targeted delivery to breast tumors while minimizing exposure to surrounding healthy tissue. This results in enhanced treatment efficacy and reduced side effects compared to conventional radiation therapy. The demand for IMRT in breast cancer cases is driven by the rising incidence of breast cancer globally, coupled with the increasing preference for advanced and precise treatment modalities that contribute to improved outcomes and better quality of life for patients undergoing radiation therapy for breast cancer.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period. These healthcare institutions invest in state-of-the-art IMRT technology and infrastructure, ensuring access to advanced radiation therapies for patients. Hospitals collaborate with radiation oncologists and technologists to deliver precise and personalized IMRT treatments. The integration of IMRT within hospital settings enhances cancer care capabilities, allowing for targeted therapy delivery and minimizing side effects. As key stakeholders, hospitals contribute significantly to the growth and accessibility of IMRT in the broader healthcare landscape.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share, driven by advanced healthcare infrastructure, a high prevalence of cancer, and robust R&D activities. The region's well-established reimbursement policies and a strong focus on technological innovation contribute to widespread adoption. Moreover, increasing awareness about the benefits of IMRT among healthcare professionals and patients enhances its market presence. Collaboration between key market players and research institutions further solidifies North America's position, ensuring a continuous surge in demand for IMRT solutions to address the evolving needs of cancer treatment in the region.

Region with highest CAGR:

The Asia Pacific region plays a significant role in the spice rum market and is projected to have the highest CAGR over the forecast period driven by increasing cancer prevalence, advancing healthcare infrastructure, and rising awareness of advanced treatment options. Countries like China, India, and Japan are at the forefront of this expansion, with growing investments in oncology care. The region's large patient pool, coupled with government initiatives to improve cancer treatment, creates a fertile ground for IMRT adoption.

Key players in the market

Some of the key players in Intensity Modulated Radiation Therapy market include Accuray Incorporated, Brainlab AG, Varian Medical Systems, Inc, Elekta AB, Hitachi, Ltd., IBA Worldwide, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, Raysearch Laboratories and Siemens Healthineers AG.

Key Developments:

In October 2023, Siemens Healthineers AG Partnered with RefleXion X to develop AI-powered solutions for optimizing IMRT treatment plans.

In June 2023, Elekta AB. acquired Monaco, a leading treatment planning software for IMRT and other modalities.

In November 2022, Accuray unveiled a strategic collaboration with Limbus AI to bolster adaptive radiotherapy solutions. This partnership marked a significant milestone in expanding Accuray's product portfolio, showcasing the company's commitment to advancing cutting-edge technologies in the field of radiotherapy.

Radiation Types Covered:

  • Proton Radiation
  • Electron Radiation
  • Photon Radiation
  • Carbon Ion Radiation
  • Other Radiation Types

Applications Covered:

  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain Cancer
  • Gynecological Cancer
  • Other Applications

End Users Covered:

  • Hospitals
  • Standalone Radiation Therapy Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Intensity Modulated Radiation Therapy Market, By Radiation Type

  • 5.1 Introduction
  • 5.2 Proton Radiation
  • 5.3 Electron Radiation
  • 5.4 Photon Radiation
  • 5.5 Carbon Ion Radiation
  • 5.6 Other Radiation Types

6 Global Intensity Modulated Radiation Therapy Market, By Application

  • 6.1 Introduction
  • 6.2 Prostate Cancer
  • 6.3 Lung Cancer
  • 6.4 Breast Cancer
  • 6.5 Brain Cancer
  • 6.6 Gynecological Cancer
  • 6.7 Other Applications

7 Global Intensity Modulated Radiation Therapy Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Standalone Radiation Therapy Centers
  • 7.4 Other End Users

8 Global Intensity Modulated Radiation Therapy Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Accuray Incorporated
  • 10.2 Brainlab AG
  • 10.3 Varian Medical Systems, Inc
  • 10.4 Elekta AB
  • 10.5 Hitachi, Ltd.
  • 10.6 IBA Worldwide
  • 10.7 Koninklijke Philips N.V.
  • 10.8 Mevion Medical Systems
  • 10.9 Mitsubishi Electric Corporation
  • 10.10 Raysearch Laboratories
  • 10.11 Siemens Healthineers AG

List of Tables

  • Table 1 Global Intensity Modulated Radiation Therapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
  • Table 3 Global Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
  • Table 4 Global Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
  • Table 5 Global Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
  • Table 6 Global Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
  • Table 7 Global Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
  • Table 8 Global Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 9 Global Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 10 Global Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 11 Global Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 12 Global Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
  • Table 13 Global Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
  • Table 14 Global Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 15 Global Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 16 Global Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 17 Global Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
  • Table 18 Global Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 19 North America Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 20 North America Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
  • Table 21 North America Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
  • Table 22 North America Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
  • Table 23 North America Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
  • Table 24 North America Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
  • Table 25 North America Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
  • Table 26 North America Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 27 North America Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 28 North America Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 29 North America Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 30 North America Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
  • Table 31 North America Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
  • Table 32 North America Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 33 North America Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 34 North America Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 35 North America Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
  • Table 36 North America Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Europe Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Europe Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
  • Table 39 Europe Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
  • Table 40 Europe Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
  • Table 41 Europe Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
  • Table 42 Europe Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
  • Table 43 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
  • Table 44 Europe Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 45 Europe Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 46 Europe Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 47 Europe Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 48 Europe Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
  • Table 49 Europe Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
  • Table 50 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 51 Europe Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 52 Europe Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 53 Europe Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
  • Table 54 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 55 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 56 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
  • Table 57 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
  • Table 58 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
  • Table 59 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
  • Table 60 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
  • Table 61 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
  • Table 62 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 63 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 64 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 65 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 66 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
  • Table 67 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
  • Table 68 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 69 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 70 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 71 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
  • Table 72 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 South America Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 South America Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
  • Table 75 South America Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
  • Table 76 South America Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
  • Table 77 South America Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
  • Table 78 South America Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
  • Table 79 South America Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
  • Table 80 South America Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 81 South America Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 82 South America Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 83 South America Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 84 South America Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
  • Table 85 South America Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
  • Table 86 South America Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 87 South America Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 88 South America Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 89 South America Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
  • Table 90 South America Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 91 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 92 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
  • Table 93 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
  • Table 94 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
  • Table 95 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
  • Table 96 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
  • Table 97 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
  • Table 98 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 99 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 100 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 101 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 102 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
  • Table 103 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
  • Table 104 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 105 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 106 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 107 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
  • Table 108 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)